Centrum Capital Valuation
Is 501150 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 501150 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 501150's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 501150's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 501150?
Other financial metrics that can be useful for relative valuation.
| What is 501150's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 501150's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 22x | ||
SPCENET Spacenet Enterprises India | 9.8x | n/a | ₹13.8b |
543766 Ashika Credit Capital | 42.8x | n/a | ₹13.4b |
500306 Jaykay Enterprises | 15x | n/a | ₹14.9b |
WEALTH Wealth First Portfolio Managers | 20.4x | n/a | ₹16.7b |
501150 Centrum Capital | 1.3x | n/a | ₹14.4b |
Price-To-Sales vs Peers: 501150 is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (22x).
Price to Earnings Ratio vs Industry
How does 501150's PE Ratio compare vs other companies in the IN Capital Markets Industry?
Price-To-Sales vs Industry: 501150 is good value based on its Price-To-Sales Ratio (1.3x) compared to the Indian Capital Markets industry average (8.1x).
Price to Sales Ratio vs Fair Ratio
What is 501150's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 501150's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.